Holen Sie sich die Stockscreener-App
2.54
0.78%
-0.02
Handel nachbörslich:
2.50
-0.04
-1.57%
Schlusskurs vom Vortag:
$2.56
Offen:
$2.6
24-Stunden-Volumen:
16,856
Relative Volume:
0.33
Marktkapitalisierung:
$77.83M
Einnahmen:
$6.21M
Nettoeinkommen (Verlust:
$-19.92M
KGV:
-2.419
EPS:
-1.05
Netto-Cashflow:
$-16.76M
1W Leistung:
+0.40%
1M Leistung:
-5.93%
6M Leistung:
-16.72%
1J Leistung:
-7.64%
1-Tages-Spanne:
$2.47
$2.60
1-Wochen-Bereich:
$2.42
$2.60
52-Wochen-Spanne:
$2.07
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Vergleichen Sie NSPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.54 | 76.28M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
133.57 | 231.29B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.17 | 157.07B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.86 | 146.67B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.74 | 104.07B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.10 | 44.71B | 5.54B | 4.18B | 623.10M | 7.00 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
Inspire Medical Systems (NYSE:INSP) and InspireMD (NYSE:NSPR) Head-To-Head Contrast - Defense World
OrthoPediatrics (NASDAQ:KIDS) versus InspireMD (NYSE:NSPR) Critical Review - Defense World
Piper Sandler Lowers InspireMD (NYSE:NSPR) Price Target to $4.00 - Defense World
InspireMD Inc. Reports Q1 2025 Financial Results - MSN
InspireMD outlines Q3 2025 FDA approval target for CGuard Prime - MSN
InspireMD Inc’s Earnings Call: Growth Amid Challenges - MSN
InspireMD (NSPR) Sees Price Target Reduction by Piper Sandler | - GuruFocus
InspireMD price target lowered to $4 from $4.50 at Piper Sandler - TipRanks
Piper Sandler cuts InspireMD stock price target to $4.00 By Investing.com - Investing.com South Africa
Piper Sandler cuts InspireMD stock price target to $4.00 - Investing.com Australia
InspireMD (NSPR) Price Target Reduced, FDA Approval Timeline Adj - GuruFocus
InspireMD (NSPR) Price Target Reduced, FDA Approval Timeline Adjusted | NSPR Stock News - GuruFocus
InspireMD initiated with a Buy at Lake Street - TipRanks
InspireMD, Inc. (NASDAQ:NSPR) Q1 2025 Earnings Call Transcript - Insider Monkey
InspireMD Inc (NSPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus
InspireMD Inc (NSPR) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges By GuruFocus - Investing.com Canada
Earnings call transcript: InspireMD Q1 2025 shows mixed results - Investing.com
InspireMD earnings beat by $0.09, revenue fell short of estimates - Investing.com Canada
InspireMD reports Q1 EPS (22c) vs (21c) last year - TipRanks
InspireMD (NSPR) Posts Slight Increase in Q1 Revenue | NSPR Stoc - GuruFocus
InspireMD Inc (NSPR) Q1 2025 Earnings: Revenue of $1.53M Beats E - GuruFocus
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic - NewsBreak: Local News & Alerts
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic By Stocktwits - Investing.com India
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
InspireMD Reports First Quarter 2025 Financial Results - The Manila Times
InspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent System - Nasdaq
Renaissance Technologies LLC Invests $27,000 in InspireMD, Inc. (NYSE:NSPR) - Defense World
INSPIREMD Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Nasdaq
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - Defense World
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference - The Manila Times
InspireMD's Revolutionary Stroke Prevention Technology Takes Center Stage at Major Healthcare Conference - Stock Titan
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD to Announce First Quarter 2025 Financial Results - GlobeNewswire
InspireMD, Inc. to Announce First Quarter 2025 Financial Results on May 9, 2025 - Nasdaq
Destination Excellence: New Clinical Partnerships Inspire MD Students, Aid Community Organizations - Drexel
InspireMD Q1 2025 Earnings: Leading Carotid Stent Developer Reveals Financial Performance Date - Stock Titan
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD at 24th Annual Needham: Strategic Moves in Healthcare By Investing.com - Investing.com Canada
InspireMD announces inducement grants under Nasdaq listing rule - TipRanks
Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD Expands Team: 299K Shares Granted to New Medical Device Experts - Stock Titan
InspireMD files $200M mixed securities shelf - MSN
InspireMD Inc Files For Mixed Shelf Of Up To $200 MillionSEC Filing - MarketScreener
InspireMD Files $200 Million Mixed Shelf - marketscreener.com
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):